
Ernesto Arturio Grano
Examiner (ID: 19022)
| Most Active Art Unit | 3735 |
| Art Unit(s) | 3728, 3788, 3735, 4147 |
| Total Applications | 1168 |
| Issued Applications | 657 |
| Pending Applications | 77 |
| Abandoned Applications | 448 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20406265
[patent_doc_number] => 20250375374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-11
[patent_title] => SHEAR-THINNING COMPOSITIONS FOR ABLATION
[patent_app_type] => utility
[patent_app_number] => 18/649744
[patent_app_country] => US
[patent_app_date] => 2022-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18649744
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/649744 | SHEAR-THINNING COMPOSITIONS FOR ABLATION | Jul 27, 2022 | Pending |
Array
(
[id] => 18700121
[patent_doc_number] => 11786609
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Lipid compound as well as lipid vector, nucleic acid lipid nanoparticle composition, and pharmaceutical preparation comprising the same
[patent_app_type] => utility
[patent_app_number] => 17/873404
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 10257
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17873404
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/873404 | Lipid compound as well as lipid vector, nucleic acid lipid nanoparticle composition, and pharmaceutical preparation comprising the same | Jul 25, 2022 | Issued |
Array
(
[id] => 17988758
[patent_doc_number] => 20220354795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => FREEZE-DRIED PRODUCT AND GAS-FILLED MICROVESICLES SUSPENSION
[patent_app_type] => utility
[patent_app_number] => 17/872974
[patent_app_country] => US
[patent_app_date] => 2022-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7739
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17872974
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/872974 | Freeze-dried product and gas-filled microvesicles suspension | Jul 24, 2022 | Issued |
Array
(
[id] => 20663587
[patent_doc_number] => 12605336
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-21
[patent_title] => Fusogenic liposome-coated porous silicon nanoparticles
[patent_app_type] => utility
[patent_app_number] => 17/871768
[patent_app_country] => US
[patent_app_date] => 2022-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 23
[patent_no_of_words] => 7055
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17871768
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/871768 | Fusogenic liposome-coated porous silicon nanoparticles | Jul 21, 2022 | Issued |
Array
(
[id] => 18418384
[patent_doc_number] => 20230172842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => SUSTAINED DRUG DELIVERY IMPLANT
[patent_app_type] => utility
[patent_app_number] => 17/812946
[patent_app_country] => US
[patent_app_date] => 2022-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812946
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812946 | SUSTAINED DRUG DELIVERY IMPLANT | Jul 14, 2022 | Abandoned |
Array
(
[id] => 20301193
[patent_doc_number] => 12447163
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-21
[patent_title] => Liposomal formulations of Bcl inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/813001
[patent_app_country] => US
[patent_app_date] => 2022-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 23
[patent_no_of_words] => 17104
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813001
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/813001 | Liposomal formulations of Bcl inhibitors | Jul 14, 2022 | Issued |
Array
(
[id] => 20606541
[patent_doc_number] => 12582118
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-24
[patent_title] => Antimicrobial coating material for surface coating
[patent_app_type] => utility
[patent_app_number] => 17/864524
[patent_app_country] => US
[patent_app_date] => 2022-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 67
[patent_no_of_words] => 5571
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17864524
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/864524 | Antimicrobial coating material for surface coating | Jul 13, 2022 | Issued |
Array
(
[id] => 18034486
[patent_doc_number] => 20220378701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => LIPID NANOPARTICLES FOR DELIVERING mRNA VACCINES
[patent_app_type] => utility
[patent_app_number] => 17/810055
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28161
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810055
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810055 | LIPID NANOPARTICLES FOR DELIVERING mRNA VACCINES | Jun 29, 2022 | Abandoned |
Array
(
[id] => 17981064
[patent_doc_number] => 20220347100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => LIPID NANOPARTICLES FOR DELIVERING mRNA VACCINES
[patent_app_type] => utility
[patent_app_number] => 17/810064
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28189
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810064
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810064 | Lipid nanoparticles for delivering mRNA vaccines | Jun 29, 2022 | Issued |
Array
(
[id] => 18108022
[patent_doc_number] => 20230000902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => OXYGEN GAS SUSTAINED RELEASED NANO-EMULSION COMPOSITION AND METHOD FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/847808
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14448
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17847808
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/847808 | Oxygen gas sustained released nano-emulsion composition and method for producing the same | Jun 22, 2022 | Issued |
Array
(
[id] => 19593230
[patent_doc_number] => 12151048
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-26
[patent_title] => Bioerodible cross-linked hydrogel implants and related methods of use
[patent_app_type] => utility
[patent_app_number] => 17/808412
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 6117
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17808412
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/808412 | Bioerodible cross-linked hydrogel implants and related methods of use | Jun 22, 2022 | Issued |
Array
(
[id] => 19170731
[patent_doc_number] => 20240156705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => COSMETIC COMPOSITION COMPRISING AT LEAST ONE POLAR OIL, A POLYOL AND AT LEAST ONE HYDROPHILIC ACTIVE AGENT
[patent_app_type] => utility
[patent_app_number] => 18/570450
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18570450
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/570450 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE POLAR OIL, A POLYOL AND AT LEAST ONE HYDROPHILIC ACTIVE AGENT | Jun 20, 2022 | Pending |
Array
(
[id] => 18792743
[patent_doc_number] => 11826477
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-11-28
[patent_title] => Metal organic framework/porous silicate and/or aluminosilicate nanocarrier for blastocystosis treatment
[patent_app_type] => utility
[patent_app_number] => 17/842876
[patent_app_country] => US
[patent_app_date] => 2022-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 14721
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842876
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/842876 | Metal organic framework/porous silicate and/or aluminosilicate nanocarrier for blastocystosis treatment | Jun 16, 2022 | Issued |
Array
(
[id] => 19563485
[patent_doc_number] => 12138235
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => Cape-loaded targeted microvesicular cancer drug and method for developing the same
[patent_app_type] => utility
[patent_app_number] => 17/840700
[patent_app_country] => US
[patent_app_date] => 2022-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3373
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17840700
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/840700 | Cape-loaded targeted microvesicular cancer drug and method for developing the same | Jun 14, 2022 | Issued |
Array
(
[id] => 19462312
[patent_doc_number] => 20240315981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => SUB-MICRON PARTICLE
[patent_app_type] => utility
[patent_app_number] => 18/570611
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18570611
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/570611 | SUB-MICRON PARTICLE | Jun 13, 2022 | Pending |
Array
(
[id] => 18829618
[patent_doc_number] => 20230398142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => METHOD FOR PREVENTING OR TREATING UROLOGICAL CHRONIC PELVIC PAIN SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/835634
[patent_app_country] => US
[patent_app_date] => 2022-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17835634
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/835634 | Method for preventing or treating urological chronic pelvic pain syndrome | Jun 7, 2022 | Issued |
Array
(
[id] => 18034520
[patent_doc_number] => 20220378735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => CABAZITAXEL WEAKLY- ALKALINE DERIVATIVE AND FORMULATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/831962
[patent_app_country] => US
[patent_app_date] => 2022-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17831962
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/831962 | CABAZITAXEL WEAKLY- ALKALINE DERIVATIVE AND FORMULATION THEREOF | Jun 2, 2022 | Pending |
Array
(
[id] => 18237870
[patent_doc_number] => 20230070180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => PROTEIN-LOADED PLGA NANOSPHERES
[patent_app_type] => utility
[patent_app_number] => 17/830615
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17830615
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/830615 | Protein-loaded PLGA nanospheres | Jun 1, 2022 | Issued |
Array
(
[id] => 17895468
[patent_doc_number] => 20220305130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => PROCESS FOR FORMULATING AN ANIONIC AGENT
[patent_app_type] => utility
[patent_app_number] => 17/831258
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17831258
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/831258 | PROCESS FOR FORMULATING AN ANIONIC AGENT | Jun 1, 2022 | Abandoned |
Array
(
[id] => 18283323
[patent_doc_number] => 20230098795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => DELIVERY OF AGENTS USING METASTABLE LIPOSOMES
[patent_app_type] => utility
[patent_app_number] => 17/829960
[patent_app_country] => US
[patent_app_date] => 2022-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9702
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17829960
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/829960 | Delivery of agents using metastable liposomes | May 31, 2022 | Issued |